Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports

Court Issues Transfer Order in Anticipation of Many More Filings

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

DALLAS (PRWEB) July 18, 2014

The number of lawsuits filed involving plaintiffs claiming they suffered adverse health affects after taking drugs associated with testosterone therapy more than doubled from June 6-16, 2014, reports the national law firm of Baron and Budd. On June 6 there were 45 such lawsuits pending in the U.S. District Court of Illinois, but by June 16 there were nearly 100 lawsuits pending. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

A Transfer Order was issued on June 6 by the U.S. Judicial Panel on Multidistrict Litigation (MDL), to consolidate lawsuits to facilitate more efficient progression of the cases. According to the Order, thousands more testosterone lawsuits could potentially be filed. (http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf) Plaintiffs in the cases are claiming that the testosterone drugs they took caused a wide range of cardiovascular issues, including strokes and heart attacks.

The U.S. Food and Drug Administration announced on January 31, 2014 that it was undergoing a review of the medications in the wake of study results that showed a potential link between the drugs and the cardiovascular issues. These studies indicated that men taking testosterone therapy medications faced a higher chance of developing health problems than men who did not take the drugs. (http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm)

On June 20, 2014, the FDA announced it would require manufacturers of testosterone therapy medications to add a warning to their labeling regarding the potential formation of blood clots. The higher risk, according to the agency, is due to a condition known as polycythemia, which is an increase in red blood cell count. Testosterone drugs have been linked to the condition.

“This momentum in testosterone therapy lawsuits is an indication that the FDA is moving in the right direction with respect to making sure the public is warned,” said Stephen Blackburn attorney at the national law firm of Baron and Budd. “We hope the FDA will consider the number of clients alleging injuries as a result of testosterone replacement therapy and take an even closer look at the widespread use of testosterone.”

Please get in touch with the national law firm of Baron and Budd if you or someone close to you suffered a stroke, blood clots or other cardiovascular problems after undergoing testosterone therapy. Call Baron and Budd at 866-472-9108 or visit our website to learn more: http://baronandbudd.com/areas-of-practice/pharmaceuticals/testosterone-therapy/.

ABOUT BARON AND BUDD

The law firm of Baron and Budd, with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with over 35 years of “Protecting What’s Right” for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals, governmental and business entities in areas as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, unsafe drugs and medical devices, Chinese drywall, deceptive advertising, consumer financial fraud, securities fraud and asbestos cancers such as mesothelioma.


Contact